EICHOR
● Active Not Recruiting
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
Condition: Systemic Lupus Erythematosus · Sponsor: Novartis Pharmaceuticals
About this study
The trial will evaluate efficacy, safety and tolerability of ianalumab compared to placebo, given as monthly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants with active systemic lupus erythematosus (SLE).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (90)
| Pinnacle Research Group LLC | Anniston, Alabama, United States | — |
| Advanced Medical Research | La Palma, California, United States | — |
| University of California LA | Los Angeles, California, United States | — |
| Homestead Assoc In Research Inc | Homestead, Florida, United States | — |
| IRIS Research and Development | Plantation, Florida, United States | — |
| Emory University | Atlanta, Georgia, United States | — |
| Willow Rheumatology Wellness | Willowbrook, Illinois, United States | — |
| Bluegrass Community Research Inc | Lexington, Kentucky, United States | — |
| Accurate Clinical Research | Lake Charles, Louisiana, United States | — |
| UMC New Orleans | New Orleans, Louisiana, United States | — |
| University Of Maryland | Baltimore, Maryland, United States | — |
| Ahmed Arif Medical Research Center | Grand Blanc, Michigan, United States | — |
+ 78 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05624749